In conclusion, our studies have proven that scutellarin alleviates Alzheimer’s-like pathology and cognitive decline by reducing Aβ levels in the brain and plasma, decreasing Aβ plaque associated gliosis and levels of proinflammatory cytokines TNF-α and IL-6, and attenuating neuroinflammation. Here, IL6 is linked to Mental deterioration.